Topper David Joseph
SEC insider (Form 3/4/5 filer). CIK 0001740378. Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2025. Located in WESTLAKE VILLAGE, CA.
Companies Topper David Joseph has filed insider reports for
- Arcutis Biotherapeutics, Inc. (ARQT): Officer, Chief Financial Officer
Topper David Joseph
CIK: 0001740378
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARQT
Arcutis Biotherapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 2, 2025ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect9.6K shares at avg. $15.80$152K - Feb 28, 2025ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect34K shares- - Sep 24, 2024ARQT
Arcutis Biotherapeutics, Inc.
SaleDirect11.6K shares at avg. $9.48$110K - Sep 21, 2024ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Sale | 9,600 | $15.80 | $151,698 | Direct |
| Feb 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | Award | 34,000 | - | - | Direct |
| Sep 24, 2024 | ARQT Arcutis Biotherapeutics, Inc. | Sale | 11,626 | $9.48 | $110,264 | Direct |
| Sep 21, 2024 | ARQT Arcutis Biotherapeutics, Inc. | Award | 60,000 | - | $0 | Direct |
1-4 of 4 transactions